查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830765

2025年全球藥物和酒精篩檢市場報告

Drug And Alcohol Screening Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，藥物和酒精篩檢市場迅速擴張，市場規模從2024年的82.7億美元成長到2025年的95.4億美元，複合年成長率達15.3%。這段時期的成長動力源自於以下因素：職場安全意識的增強、政府強制藥物檢測需求的增加、公共安全擔憂的加劇、藥物濫用治療計畫的擴展、刑事司法系統的廣泛應用以及酒精相關交通事故的增加。

預計未來幾年藥物和酒精篩檢市場將快速成長，到2029年將達到166.9億美元，年複合成長率（CAGR）為15.0%。預測期內的成長可歸因於青少年吸毒現象的增加、現場檢測解決方案的採用率不斷提高、職場合規性要求的不斷提高、就業藥物篩檢需求的不斷成長、醫療保健篩檢計畫的擴展以及對學校藥物檢測的日益重視。預測期內的主要趨勢包括快速檢測套組的技術進步、多面板藥物檢測設備的創新、生物感測器的研發、攜帶式篩檢技術投資的增加以及實驗室自動化和機器人系統的進步。

藥物和酒精篩檢是一個結構化的流程，旨在使用經過科學檢驗的檢測技術來識別和量化個體體內藥物或酒精的存在。這項程序對於確保安全、遵守監管標準以及在各種個人、職業和法律情況下支持明智的決策至關重要。

藥物和酒精篩檢中使用的主要檢體類型包括尿液、口腔液、頭髮和其他檢體。尿液檢體是最常被採集的生物檢體之一，用於檢測藥物、酒精或其代謝物。這種方法非侵入性、經濟高效，尤其適用於偵測近期吸毒情況。尿液檢查廣泛應用於職場、刑事司法和執法系統、藥物治療計畫、疼痛管理診所和檢測實驗室。我們服務於廣泛的終端用戶，包括醫院、治療中心、執法機構和體育組織。

2025年春季美國突然提高關稅以及由此引發的貿易摩擦對醫療保健產業產生了嚴重影響，特別是對關鍵醫療設備、診斷設備和藥品的供應。醫院和醫療機構面臨進口手術器械、影像設備以及注射器和導管等消耗品成本上漲的問題。這些成本上漲給醫療保健預算帶來了壓力，導致一些醫療機構推遲設備升級或將成本轉嫁給患者。此外，原料和零件的關稅阻礙了基本藥品和醫療設備的生產，造成了供應鏈瓶頸。作為應對措施，該行業正在籌資策略多樣化，盡可能促進本地生產，並倡導對緊急醫療產品免關稅。

本研究報告是篩檢 ）新報告系列的一部分，該系列提供藥物和酒精篩檢市場統計數據，例如藥物和酒精篩檢行業的全球市場規模、各地區佔有率、各競爭對手的市場佔有率、藥物和酒精篩檢市場的詳細細分、市場趨勢和商業機會，以及在藥物和酒精篩檢篩檢篩檢報告對該行業的現狀和未來情況進行了詳細分析，為您提供全面的觀點所需的所有資訊。

預計麻醉品和非法藥物的使用增加將在未來幾年推動藥物和酒精篩檢市場的成長。麻醉品和非法藥物是作用於中樞神經系統的物質，常用於緩解疼痛和改變心智。越來越多的人開始使用藥物來應對日益嚴重的心理健康問題，例如焦慮、憂鬱症和創傷，藥物使用也正在增加。藥物和酒精篩檢透過支持職場、醫療保健和法律環境中的早期發現、安全和及時干預來幫助應對這一趨勢。例如，2023 年 11 月，美國衛生與公眾服務部下屬的藥物濫用和精神健康服務管理局 (SAMHSA) 報告稱，2022 年約有 7,000 萬 12 歲及以上的美國（約佔總人口的 25%）使用了非法藥物，比 2021 年增加了約 15%。因此，麻醉品和非法藥物的使用增加正在推動藥物和酒精篩檢市場的發展。

藥物和酒精篩檢市場的主要企業正在開發先進的解決方案，例如穿戴式酒精檢測軟體，以提高篩檢程序的準確性、速度和可靠性。酒精檢測軟體是一種數位工具，可處理和管理來自酒精測試設備的數據，從而實現即時監控、自動報告和增強安全關鍵環境中的合規性。例如，2024 年 10 月，美國行為健康與安全公司 Sobrsafe Inc. 推出了一個用於酒精檢測和監控的完全整合的企業軟體平台。該系統結合了兩種關鍵產品，用於即時篩檢的SOBRcheck 和用於持續監控的 SOBRsure，並使用先進的基於觸摸的經皮酒精檢測，從而無需進行侵入性呼吸、血液和尿液檢查。該平台與電子健康記錄(EMR) 無縫整合，並透過可從電腦和行動裝置存取的統一儀表板提供跨多個使用者和位置的即時可見性。

2024年5月，專注於居家和虛擬診斷的美國醫療科技公司eMed LLC與i3screen合作，為雇主推出了一項虛擬藥物篩檢計畫。該舉措為雇主提供了一種便捷、完全遠端、即時的口服藥物篩檢解決方案，簡化了入職前的檢測流程，加快了招聘決策，並保持了檢測的完整性和合規性。

藥物和酒精篩檢市場涵蓋營業單位透過提供營業單位前篩檢、隨機檢測、合理懷疑檢測、康復和監測項目以及後續檢測等服務所獲得的收益。市場價值包括服務提供者銷售或包含在服務產品中的相關商品的價值。僅包括實體之間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球藥物和酒精篩檢：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球藥物和酒精篩檢市場：成長率分析
  • 全球藥物與酒精篩檢市場表現：規模與成長，2019-2024
  • 全球藥物與酒精篩檢市場預測：規模與成長，2024-2029 年，2034 年
  • 全球藥物和酒精篩檢：總目標市場（TAM）

第6章 市場細分

  • 全球藥物和酒精篩檢市場（按樣本類型）：表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 尿液樣本
  • 口腔液體樣本
  • 頭髮樣本
  • 其他樣本類型
  • 全球藥物和酒精篩檢市場的應用、表現和預測（2019-2024 年、2024-2029 年、2034 年）
  • 職場
  • 刑事司法和執法系統
  • 戒毒中心
  • 疼痛管理中心
  • 藥物檢測實驗室
  • 全球藥物和酒精篩檢市場（按最終用戶、業績和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院和治療設施
  • 司法/執行
  • 體育賽事
  • 其他最終用戶
  • 全球藥物與酒精篩檢市場：尿液樣本（類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 實驗室尿液檢查
  • 即時或快速尿液檢查
  • 全球藥物與酒精篩檢市場：依口腔液體樣本細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 現場口腔液體檢測
  • 臨床口腔液體檢測
  • 全球藥物與酒精篩檢市場：依頭髮樣本細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 頭髮檢查
  • 體毛測試
  • 全球藥物和酒精篩檢市場：按其他樣本類型細分（按類型）、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 汗斑測試
  • 酒精測試
  • 血液檢查

第7章 區域和國家分析

  • 全球藥物和酒精篩檢市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球藥物和酒精篩檢市場：按國家、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 藥物和酒精篩檢市場：競爭格局
  • 藥物和酒精篩檢市場：公司簡介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Dragerwerk AG & Co. KGaA
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Randox Laboratories Ltd.
  • OraSure Technologies Inc.
  • MEDTOX Laboratories Inc.
  • Psychemedics Corporation
  • SureHire Inc.
  • Alcohol Countermeasure Systems Corp.
  • Phamatech Inc.
  • Premier Biotech Inc.
  • Alfa Scientific Designs Inc.
  • Omega Laboratories Inc.
  • Lifeloc Technologies Inc.
  • Smartox Biotechnology SAS

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年藥物和酒精篩檢市場：提供新機會的國家
  • 2029 年藥物和酒精篩檢市場：細分市場帶來新機會
  • 2029 年藥物與酒精篩檢市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r37753

Drug and alcohol screening is a structured process designed to identify and quantify the presence of drugs or alcohol in an individual's system using scientifically validated testing techniques. This procedure is essential for ensuring safety, maintaining compliance with regulatory standards, and supporting informed decision-making in various personal, professional, and legal contexts.

The primary types of samples used in drug and alcohol screening include urine, oral fluid, hair, and other specimens. Urine samples are one of the most commonly collected biological specimens, used to detect drugs, alcohol, or their metabolites. This method is non-invasive, cost-effective, and particularly effective for detecting recent substance use. Urine testing finds applications in workplaces, criminal justice and law enforcement systems, drug treatment programs, pain management clinics, and testing laboratories. It serves a wide range of end users, including hospitals, treatment centers, law enforcement agencies, sports organizations, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The drug and alcohol screening market research report is one of a series of new reports from The Business Research Company that provides drug and alcohol screening market statistics, including drug and alcohol screening industry global market size, regional shares, competitors with a drug and alcohol screening market share, detailed drug and alcohol screening market segments, market trends and opportunities, and any further data you may need to thrive in the drug and alcohol screening industry. This drug and alcohol screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug and alcohol screening market size has grown rapidly in recent years. It will grow from $8.27 billion in 2024 to $9.54 billion in 2025 at a compound annual growth rate (CAGR) of 15.3%. The growth during the historical period can be attributed to heightened awareness of workplace safety, increased demand for government-mandated drug testing, growing concerns about public safety, the expansion of substance abuse treatment programs, wider adoption in criminal justice systems, and a rise in alcohol-related traffic incidents.

The drug and alcohol screening market size is expected to see rapid growth in the next few years. It will grow to $16.69 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth during the forecast period can be attributed to the rising use of narcotics among youth, increasing adoption of on-site testing solutions, expanding workplace compliance requirements, growing demand for employment drug screening, the expansion of healthcare screening programs, and greater emphasis on school-based drug testing. Key trends in the forecast period include technological advancements in rapid testing kits, innovations in multi-panel drug testing devices, research and development in biosensors, increased investment in portable screening technologies, and progress in laboratory automation and robotic systems.

The rising use of narcotics and illegal drugs is expected to drive the growth of the drug and alcohol screening market in the coming years. Narcotics and illegal drugs are substances that affect the central nervous system, often used for pain relief or mind-altering effects. Their usage is increasing as more individuals turn to substances to cope with rising mental health issues such as anxiety, depression, and trauma. Drug and alcohol screening helps address this trend by enabling early detection, ensuring safety, and supporting timely interventions in workplaces, healthcare, and legal settings. For example, in November 2023, the Substance Abuse and Mental Health Services Administration (SAMHSA), a US-based branch of the Department of Health and Human Services, reported that approximately 70 million Americans aged 12 or older, about 25% of the population, used illicit substances in 2022, reflecting an increase of roughly 15% from 2021. Therefore, the growing use of narcotics and illegal drugs is propelling the drug and alcohol screening market.

Leading companies in the drug and alcohol screening market are developing advanced solutions, such as wearable alcohol detection software, to improve the accuracy, speed, and reliability of screening procedures. Alcohol detection software is a digital tool that processes and manages data from alcohol testing devices, enabling real-time monitoring, automated reporting, and enhanced compliance in safety-critical environments. For instance, in October 2024, Sobrsafe Inc., a US-based behavioral health safety company, launched a fully integrated enterprise software platform for alcohol detection and monitoring. The system combines two key products, SOBRcheck for point-of-care screening and SOBRsure for continuous monitoring, using advanced touch-based transdermal alcohol detection, eliminating the need for invasive breath, blood, or urine tests. The platform provides real-time visibility across multiple users and locations through a unified dashboard accessible on computers and mobile devices, integrating seamlessly with electronic medical records (EMR).

In May 2024, eMed LLC, a US-based healthcare technology company specializing in at-home and virtual diagnostics, partnered with i3screen to launch a virtual drug screening program for employers. This initiative provides employers with a convenient, fully remote, and instant oral drug screening solution, streamlining pre-employment testing, enabling faster hiring decisions, and maintaining test integrity and compliance. i3screen is a US-based company specializing in screening management systems, including drug and alcohol testing solutions.

Major players in the drug and alcohol screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Dragerwerk AG & Co. KGaA, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Randox Laboratories Ltd., OraSure Technologies Inc., MEDTOX Laboratories Inc., Psychemedics Corporation, SureHire Inc., Alcohol Countermeasure Systems Corp., Phamatech Inc., Premier Biotech Inc., Alfa Scientific Designs Inc., Omega Laboratories Inc., Lifeloc Technologies Inc., Smartox Biotechnology SAS, Millennium Health LLC, Aegis Sciences Corporation, Cordant Health Solutions Inc., and Intoximeters Inc.

North America was the largest region in the drug and alcohol screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in drug and alcohol screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the drug and alcohol screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug and alcohol screening market includes revenues earned by entities by providing services, such as pre-employment screening, random testing, reasonable suspicion testing, rehabilitation and monitoring programs, and follow-up testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug And Alcohol Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug and alcohol screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug and alcohol screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug and alcohol screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Sample Type: Urine Samples; Oral Fluid Samples; Hair Samples; Other Sample Types
  • 2) By Application: Work Place; Criminal Justice Systems And Law Enforcing Systems; Drug Treatment Centers; Pain Management Centers; Drug Testing Laboratories
  • 3) By End-User: Hospitals And Treatment Facilities; Law And Enforcement; Sporting Events, Other End-Users
  • Subsegments:
  • 1) By Urine Samples: Laboratory-Based Urine Testing; Instant Or Rapid Urine Testing
  • 2) By Oral Fluid Samples: On-Site Oral Fluid Testing; Laboratory-Based Oral Fluid Testing
  • 3) By Hair Samples: Head Hair Testing; Body Hair Testing
  • 4) By Other Sample Types: Sweat Patch Testing; Breathalyzer Testing; Blood Testing
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Dragerwerk AG & Co. KGaA; Agilent Technologies Inc.; Bio-Rad Laboratories Inc.; Randox Laboratories Ltd.; OraSure Technologies Inc.; MEDTOX Laboratories Inc.; Psychemedics Corporation; SureHire Inc.; Alcohol Countermeasure Systems Corp.; Phamatech Inc.; Premier Biotech Inc.; Alfa Scientific Designs Inc.; Omega Laboratories Inc.; Lifeloc Technologies Inc.; Smartox Biotechnology SAS; Millennium Health LLC; Aegis Sciences Corporation; Cordant Health Solutions Inc.; Intoximeters Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug And Alcohol Screening Market Characteristics

3. Drug And Alcohol Screening Market Trends And Strategies

4. Drug And Alcohol Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Drug And Alcohol Screening Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Drug And Alcohol Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Drug And Alcohol Screening Market Growth Rate Analysis
  • 5.4. Global Drug And Alcohol Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Drug And Alcohol Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Drug And Alcohol Screening Total Addressable Market (TAM)

6. Drug And Alcohol Screening Market Segmentation

  • 6.1. Global Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other Sample Types
  • 6.2. Global Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Work Place
  • Criminal Justice Systems And Law Enforcing Systems
  • Drug Treatment Centres
  • Pain Management Centres
  • Drug Testing Laboratories
  • 6.3. Global Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Treatment Facilities
  • Law And Enforcement
  • Sporting Events
  • Other End Users
  • 6.4. Global Drug And Alcohol Screening Market, Sub-Segmentation Of Urine Samples, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory-Based Urine Testing
  • Instant Or Rapid Urine Testing
  • 6.5. Global Drug And Alcohol Screening Market, Sub-Segmentation Of Oral Fluid Samples, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On-Site Oral Fluid Testing
  • Laboratory-Based Oral Fluid Testing
  • 6.6. Global Drug And Alcohol Screening Market, Sub-Segmentation Of Hair Samples, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Head Hair Testing
  • Body Hair Testing
  • 6.7. Global Drug And Alcohol Screening Market, Sub-Segmentation Of Other Sample Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sweat Patch Testing
  • Breathalyzer Testing
  • Blood Testing

7. Drug And Alcohol Screening Market Regional And Country Analysis

  • 7.1. Global Drug And Alcohol Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Drug And Alcohol Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug And Alcohol Screening Market

  • 8.1. Asia-Pacific Drug And Alcohol Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug And Alcohol Screening Market

  • 9.1. China Drug And Alcohol Screening Market Overview
  • 9.2. China Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug And Alcohol Screening Market

  • 10.1. India Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug And Alcohol Screening Market

  • 11.1. Japan Drug And Alcohol Screening Market Overview
  • 11.2. Japan Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug And Alcohol Screening Market

  • 12.1. Australia Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug And Alcohol Screening Market

  • 13.1. Indonesia Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug And Alcohol Screening Market

  • 14.1. South Korea Drug And Alcohol Screening Market Overview
  • 14.2. South Korea Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug And Alcohol Screening Market

  • 15.1. Western Europe Drug And Alcohol Screening Market Overview
  • 15.2. Western Europe Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug And Alcohol Screening Market

  • 16.1. UK Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug And Alcohol Screening Market

  • 17.1. Germany Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug And Alcohol Screening Market

  • 18.1. France Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug And Alcohol Screening Market

  • 19.1. Italy Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug And Alcohol Screening Market

  • 20.1. Spain Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug And Alcohol Screening Market

  • 21.1. Eastern Europe Drug And Alcohol Screening Market Overview
  • 21.2. Eastern Europe Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug And Alcohol Screening Market

  • 22.1. Russia Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug And Alcohol Screening Market

  • 23.1. North America Drug And Alcohol Screening Market Overview
  • 23.2. North America Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug And Alcohol Screening Market

  • 24.1. USA Drug And Alcohol Screening Market Overview
  • 24.2. USA Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug And Alcohol Screening Market

  • 25.1. Canada Drug And Alcohol Screening Market Overview
  • 25.2. Canada Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug And Alcohol Screening Market

  • 26.1. South America Drug And Alcohol Screening Market Overview
  • 26.2. South America Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug And Alcohol Screening Market

  • 27.1. Brazil Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug And Alcohol Screening Market

  • 28.1. Middle East Drug And Alcohol Screening Market Overview
  • 28.2. Middle East Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug And Alcohol Screening Market

  • 29.1. Africa Drug And Alcohol Screening Market Overview
  • 29.2. Africa Drug And Alcohol Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Drug And Alcohol Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Drug And Alcohol Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug And Alcohol Screening Market Competitive Landscape And Company Profiles

  • 30.1. Drug And Alcohol Screening Market Competitive Landscape
  • 30.2. Drug And Alcohol Screening Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Drug And Alcohol Screening Market Other Major And Innovative Companies

  • 31.1. Dragerwerk AG & Co. KGaA
  • 31.2. Agilent Technologies Inc.
  • 31.3. Bio-Rad Laboratories Inc.
  • 31.4. Randox Laboratories Ltd.
  • 31.5. OraSure Technologies Inc.
  • 31.6. MEDTOX Laboratories Inc.
  • 31.7. Psychemedics Corporation
  • 31.8. SureHire Inc.
  • 31.9. Alcohol Countermeasure Systems Corp.
  • 31.10. Phamatech Inc.
  • 31.11. Premier Biotech Inc.
  • 31.12. Alfa Scientific Designs Inc.
  • 31.13. Omega Laboratories Inc.
  • 31.14. Lifeloc Technologies Inc.
  • 31.15. Smartox Biotechnology SAS

32. Global Drug And Alcohol Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug And Alcohol Screening Market

34. Recent Developments In The Drug And Alcohol Screening Market

35. Drug And Alcohol Screening Market High Potential Countries, Segments and Strategies

  • 35.1 Drug And Alcohol Screening Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Drug And Alcohol Screening Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Drug And Alcohol Screening Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer